Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
An Ozempic pen contains semaglutide, a GLP-1 receptor agonist that reduces appetite and slows stomach emptying to support weight loss. Each pen typically holds 2 or 3 milliliters of liquid, but the actual medication dose you inject increases gradually over 16 weeks—starting low to let your body adjust and minimize side effects.
Understanding Ozempic Pen Contents and Concentration
Ozempic pens come prefilled with 2 mL or 3 mL of solution containing semaglutide at a concentration of 2.4 mg/mL. This means a single full 3 mL pen holds up to 7.2 mg of total medication. However, you do not inject the entire pen at once; instead, you use your pen to select and deliver individual doses week by week as prescribed by your healthcare provider.
The pen's dial mechanism allows precise dose selection in 0.25 mg increments, ranging from 0.25 mg to 2.4 mg per injection. This accuracy ensures you receive the exact amount needed for your current phase of treatment. Many patients are surprised to learn that their first dose is quite small—typically 0.25 mg—because starting low reduces nausea and gastrointestinal discomfort while your body adapts to the medication's effects.
The 16-Week Dose Escalation Schedule Explained
Your semaglutide journey follows a structured escalation plan that increases your dose every four weeks. Week 1 begins with 0.25 mg, week 5 advances to 0.5 mg, week 9 moves to 1.0 mg, week 13 increases to 1.7 mg, and week 17 reaches the common maintenance dose of 2.4 mg. This gradual progression is intentional—it gives your gastrointestinal system time to acclimate while your appetite-suppressing benefits steadily grow.
Some patients may stay at 1.7 mg as their effective maintenance dose if they experience adequate weight loss and good tolerability at that level. Others might continue to 2.4 mg if their healthcare provider determines additional support is beneficial. The key principle is individualization: your dose progresses at a pace that keeps side effects manageable while maximizing your results.
What to Expect During Your First Month on Semaglutide
During your first four weeks at the 0.25 mg starting dose, most patients notice reduced hunger and increased feelings of fullness from smaller meal portions. You may experience mild nausea, especially if you eat high-fat foods, but this typically diminishes within the first two weeks as your body acclimates. Weight loss during month one is often modest—typically 2 to 5 pounds—but this represents metabolic change and appetite regulation taking hold.
Side effects are generally most pronounced in the first two to three weeks, then improve as your body adjusts. Common experiences include slight appetite suppression, changes in taste preferences, and occasional mild gastrointestinal adjustments. Staying hydrated, eating smaller meals, and avoiding greasy foods significantly reduces discomfort and helps you tolerate the medication well.
How PlexusDx Compounded Semaglutide Injection Compares
PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies at a flat rate starting at $149 per month—without flat per-compound pricing changes. This means your price stays the same whether you're at the 0.25 mg starting dose or your 2.4 mg maintenance dose. Your dose may need to go up. Your price won't. This transparent, predictable pricing removes financial barriers to accessing proven weight loss medication across all 50 states.
PlexusDx accepts no insurance but remains HSA and FSA eligible, making treatment affordable for patients seeking personalized, science-backed GLP-1 therapy. If you want to understand whether genetic factors in your peptide pathways might influence your response to semaglutide, PlexusDx offers the Precision Peptide Genetic Test—a $99 add-on after your first month—which analyzes 14 metabolic pathways, 49 peptides, and key variants like GLP1R rs6923761 to guide treatment optimization.
Weight Loss Timeline and Realistic Expectations
Semaglutide weight loss typically follows a progressive pattern: month one yields 2–5 pounds, months two and three bring 3–7 pounds each as your dose escalates, and by month four at a higher dose, weight loss often accelerates to 5–10 pounds per month for many patients. Total loss over 16 weeks commonly reaches 10–20 pounds, with continued loss possible as you stabilize at your maintenance dose. Individual results vary based on diet quality, physical activity, metabolism, and adherence to the medication schedule.
Most significant weight loss happens between weeks 8 and 24, when your dose reaches therapeutic levels and your body has fully adapted to GLP-1 signaling. After six months, many patients report losing 15–25% of their starting body weight. Realistic long-term expectations include sustained weight loss as long as you continue the medication and maintain healthy eating habits; stopping semaglutide often leads to gradual weight regain over months.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much semaglutide is actually in one Ozempic pen?
A standard Ozempic pen contains 2 mL or 3 mL of solution with 2.4 mg/mL concentration. A full 3 mL pen holds 7.2 mg total, but you inject only your prescribed dose—starting at 0.25 mg and escalating weekly over 16 weeks. The pen's dial lets you select precise doses up to 2.4 mg per injection.
When will I see weight loss results on semaglutide?
Most patients notice reduced hunger in the first week and see the scale move within 2–4 weeks at the starting 0.25 mg dose. Significant weight loss accelerates around week 8–12 as your dose reaches 1.0–1.7 mg. Total weight loss of 10–20 pounds in the first four months is typical, with many patients losing 15–25% of body weight over six months.
What does PlexusDx semaglutide cost compared to brand-name Ozempic?
PlexusDx compounded semaglutide injection starts at $149 per month—a flat rate across all dose levels. No insurance required, HSA/FSA eligible, and available in all 50 states. Your dose may increase, but your price stays the same, making treatment predictable and affordable versus brand-name options.
What side effects should I expect in the first month?
Mild nausea, reduced appetite, and occasional gastrointestinal changes are common in weeks 1–3 at the 0.25 mg starting dose. Most side effects resolve as your body adjusts. Eating smaller meals, staying hydrated, and avoiding high-fat foods significantly minimize discomfort. Serious side effects are rare but should be reported to your provider immediately.
Can genetic testing help personalize my semaglutide response?
Yes. PlexusDx Precision Peptide Genetic Test ($99 after your first month) analyzes variants like GLP1R rs6923761 and other markers across 14 metabolic pathways to reveal your peptide-pathway predispositions. This insight helps your provider optimize your treatment plan and explain why you may respond differently than others.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What’s Better for Weight Loss: Tirzepatide or Semaglutide?
Optimizing Your Wellness: Can You Take Vitamin D with Semaglutide?